Jan Cools

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Jan Cools

Jul 14, 2024, 07:13 | Blog

The main scientific topics of ESHALL2025

ESH (European School of Haematology) shared a post on X: ''The main scientific topics of…

Jul 4, 2024, 08:53 | Blog

Jan Cools: 2023 journal impact factor of HemaSphere Journal is 12.1

Jan Cools, Editor in Chief of HemaSphere, journal of EHA at European Hematology Association (EHA), made…

Mar 9, 2024, 14:13 | Insight

Jan Cools: A single-cell expression atlas of 119,000 AML cells and AML stem cells in paired diagnostic-relapse samples

Jan Cools, Editor in Chief of HemaSphere, journal of EHA at European Hematology Association (EHA), shared…

Sep 9, 2023, 20:36 | Blog

Jan Cools: I am very excited to announce an update on the 2022 journal impact factor of Hema Sphere Journal - the new projected impact factor is 9.1 and will be released by Clarivate in the October JCR update.

All: 4 Posts: 1 - 100

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023